Taken together with previous research, this implicates that alleviation of post-prandial hypoglycemia after RYGB via GLP-1 receptor agonist treatment likely involves other mechanisms than acute effects on conventional counter-regulatory hormones. This evidence concerns the gene GLP1R and Hypoglycemia.